SNTA1-deficient human cardiomyocytes demonstrate hypertrophic phenotype and calcium handling disorder
Summary
SNTA1-deficient cardiomyocytes can be used to research the etiology, pathogenesis, and potential therapies for myocardial diseases. The SNTA1-deficient cardiomyocyte model suggests that the maintenance of cardiac calcium homeostasis is a key target in the treatment of myocardial-related diseases. © 2022. The Author(s).
| Authors | Dong T, Zhao Y, Jin HF, Shen L, Lin Y, Si LL, Chen L, Liu JC |
|---|---|
| Journal | Stem cell research & therapy |
| Publication Date | 2022 Jun 30;13(1):288 |
| PubMed | 35773684 |
| PubMed Central | PMC9248201 |
| DOI | 10.1186/s13287-022-02955-4 |